Search results for "double-blind method"

showing 10 items of 631 documents

Training Effects of Alternated and Pulsed Currents on the Quadriceps Muscles of Athletes

2018

AbstractThe aim of the study was to evaluate the effects of 6 weeks training with different neuromuscular electrical stimulation (NMES) currents (medium alternated and low-frequency pulsed current) on muscle architecture and neuromuscular performance of competitive athletes. A double-blind controlled and randomized experimental study was carried out with 33 athletes (22.2±2.6 yrs, 74.7±9.8 kg, 176.8±6.0 cm), divided into 3 groups: mid-frequency current (MF, n=12), pulsed current (PC, n=11) and the control group (CG, n=10). Quadriceps maximal voluntary peak torque (PT) and corresponding vastus lateralis electromyographic activity, evoked torque (PT-NMES), vastus lateralis muscle thickness, f…

Malemedicine.medical_specialtyMuscle trainingVisual Analog ScaleVastus lateralis musclePhysical Therapy Sports Therapy and RehabilitationCompetitive athletesElectromyographyAthletic PerformanceQuadriceps MuscleYoung Adult03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationDouble-Blind MethodmedicineHumansOrthopedics and Sports MedicineMuscle StrengthTraining periodmedicine.diagnostic_testElectromyographybusiness.industryQuadriceps Muscles030229 sport sciencesElectric StimulationTorqueFascicle lengthbusinessMuscle architecture030217 neurology & neurosurgeryInternational Journal of Sports Medicine
researchProduct

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.

2019

Purpose: To evaluate the additive intraocular pressure–lowering effect of twice-daily brinzolamide 1%/brimonidine 0.2% fixed-dose combination (BBFC) as an adjunct to a prostaglandin analog (PGA) in patients with open-angle glaucoma or ocular hypertension insufficiently controlled with PGA monotherapy. Methods: In this Phase 4, double-masked trial, patients aged ⩾18 years, with a mean intraocular pressure of ⩾19 and <32 mm Hg in at least one eye were randomized (1:1) to receive BBFC + PGA ( n = 96) or vehicle + PGA ( n = 92) for 6 weeks. The primary endpoint was the mean change in diurnal intraocular pressure from baseline (averaged over 09:00 and 11:00 h) at Week 6. Results: The mean diu…

Malemedicine.medical_specialtyOpen angle glaucomagenetic structuresFixed-dose combinationBrinzolamideThiazinesOcular hypertensionopen-angle glaucoma03 medical and health sciencesTonometry Ocular0302 clinical medicineTravoprostDouble-Blind Methodintraocular pressure reductionOphthalmologyOriginal Research ArticlesmedicineAdrenergic alpha-2 Receptor AgonistsHumansCarbonic Anhydrase InhibitorsAntihypertensive AgentsIntraocular PressureAgedAged 80 and overSulfonamidesbusiness.industryprostaglandin analogsBrimonidineBrinzolamide/brimonidine fixed-dose combinationGeneral MedicineMiddle Agedmedicine.diseaseAdjuncteye diseasesOphthalmologyDrug CombinationsProstaglandin analogBrimonidine Tartrate030221 ophthalmology & optometryLatanoprostocular hypertensionFemalesense organsbusiness030217 neurology & neurosurgeryGlaucoma Open-Anglemedicine.drugEuropean journal of ophthalmology
researchProduct

Pacemaker-Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot Study.

2021

Background In prior unblinded studies, cardiac neuromodulation therapy (CNT) employing a sequence of variably timed short and longer atrioventricular intervals yielded sustained reductions of systolic blood pressure (SBP) in patients with hypertension. The effects of CNT on SBP were investigated in this double‐blind randomized pilot study. Methods and Results Eligible patients had daytime ambulatory SBP (aSBP) ≥130 mm Hg and office SBP ≥140 mm Hg despite taking ≥1 antihypertensive medication, and an indication for a dual‐chamber pacemaker. Patients underwent Moderato device implantation, which was programmed as a standard pacemaker during a 1‐month run‐in phase. Patients whose daytime aSBP…

Malemedicine.medical_specialtyPacemaker ArtificialTime Factorshypertensionatrioventricular interval ; hypertension ; left ventricular function ; pacemakerBlood PressurePilot ProjectsArrhythmiasVentricular Function LeftDouble-Blind MethodHeart RateInternal medicineMedicineHumansIn patientProspective StudiesSequence (medicine)AgedOriginal ResearchAged 80 and overbusiness.industryCardiac Pacing ArtificialEditorialsHeartNeuromodulation (medicine)EuropeTreatment OutcomeEditorialCardiologyFemaleCardiology and Cardiovascular Medicinebusinesshigh blood pressureJournal of the American Heart Association
researchProduct

Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial

2014

A limited number of nondigestible oligosaccharides are available for use in infant formula. This study evaluated growth and safety in infants fed formula supplemented with a mixture of bovine milk-derived oligosaccharides (BMOS). This mixture, which was generated from whey permeate, contains galactooligosaccharides and other oligosaccharides from bovine milk, such as 3′- and 6′-sialyllactose. We hypothesized that growth in infants fed BMOS-supplemented formula would be noninferior to that in infants fed standard formula. Healthy term infants ≤14 days old were randomly assigned to standard formula (control; n = 84); standard formula with BMOS (IF-BMOS; n = 99); or standard formula with BMOS …

Malemedicine.medical_specialtyPediatricsBifidobacterium longumOligosaccharidesGrowthWeight GainGastroenterologyInfant nutritionFecesChild DevelopmentLactobacillus rhamnosusDouble-Blind MethodInternal medicinemedicineAnimalsHumansPediatrics Perinatology and Child HealthGastrointestinal TransitFecesHealthy infantsbiologyAnthropometrybusiness.industryProbioticsInfant NewbornInfantbiology.organism_classificationConfidence intervalInfant FormulaMilkInfant formulaPediatrics Perinatology and Child HealthFood FortifiedVomitingCattleFemalemedicine.symptombusinessFlatulenceWeight gainBovine milk-derived oligosaccharidesResearch ArticleBMC Pediatrics
researchProduct

Intolerance of Cow's Milk and Chronic Constipation in Children

1998

Background Chronic diarrhea is the most common gastrointestinal symptom of intolerance of cow's milk among children. On the basis of a prior open study, we hypothesized that intolerance of cow's milk can also cause severe perianal lesions with pain on defecation and consequent constipation in young children. Methods We performed a double-blind, crossover study comparing cow's milk with soy milk in 65 children (age range, 11 to 72 months) with chronic constipation (defined as having one bowel movement every 3 to 15 days). All had been referred to a pediatric gastroenterology clinic and had previously been treated with laxatives without success; 49 had anal fissures and perianal erythema or e…

Malemedicine.medical_specialtyPediatricsSettore MED/09 - Medicina InternaConstipationErythemaEosinophilDouble-Blind MethodmedicineAnimalsHumansInflammationChronic constipationCross-Over StudiesAnimalbusiness.industryMedicine (all)RectumInfantfood and beveragesGeneral MedicineCross-Over Studiemedicine.diseaseCrossover studySurgeryEosinophilsFood intoleranceMilkEl NiñoChild PreschoolChronic DiseaseEtiologyDefecationFemaleInfant FoodSoybeansFissure in AnoMilk Hypersensitivitymedicine.symptomSoybeanbusinessConstipationHumanNew England Journal of Medicine
researchProduct

Effects of nicotinamide adenine dinucleotide hydride on physical and mental performance

2007

The aim of this study was to assess the effects of nicotinamide adenine dinucleotide hydride (NADH) on maximal oxygen uptake (VO2max), maximal anaerobic running time, and mental performance. Eight men were exposed to a supplement treatment (30 mg NADH as ENACHI tablets per day) and to a placebo treatment, each of 4 weeks' duration, in a balanced, double-blind, and cross-over design. The two treatments were separated by a 14-week wash-out period. The results indicated that VO2max, maximal anaerobic running time, and the ability to concentrate were similar in the NADH and placebo conditions. There were also no differences in blood lactate, creatine kinase, reaction time or feelings of fatigue…

Malemedicine.medical_specialtyPhysical Therapy Sports Therapy and RehabilitationNicotinamide adenine dinucleotidePlaceboPlaceboschemistry.chemical_compoundCognitionOxygen ConsumptionDouble-Blind MethodInternal medicinemedicineHumansOrthopedics and Sports MedicineLactic AcidCreatine KinaseCross-Over StudiesNicotinamidebiologyHydrideVO2 maxNADB vitaminsEndocrinologyBiochemistrychemistryAustriaExercise Testbiology.proteinCreatine kinaseAnaerobic exerciseJournal of Sports Sciences
researchProduct

Efficacy of delayed thromboprophylaxis with dabigatran: Pooled analysis

2012

Abstract Introduction Oral thromboprophylaxis with dabigatran etexilate should be initiated as a half dose 1 to 4 h after major orthopaedic surgery. However, a delay in dosing could occur for clinical or logistical reasons. A post hoc analysis was carried out to determine if patients with delayed dosing received adequate anticoagulation. Patients and methods The RE-MODEL™ and RE-NOVATE® trials compared 220 mg and 150 mg dabigatran etexilate with 40 mg enoxaparin. Pooled data for major venous thromboembolism (VTE) and VTE-related mortality (efficacy outcome) and major bleeding events (MBE), MBE/clinically relevant bleeding events, and all bleeding events (safety outcomes) were analysed. Resu…

Malemedicine.medical_specialtyPyridinesAntithrombinsDrug Administration ScheduleDabigatranlaw.inventionDouble-Blind MethodRandomized controlled triallawPost-hoc analysisHumansMedicineOrthopedic ProceduresProspective StudiesDosingEnoxaparinProspective cohort studyAgedbusiness.industryAnticoagulantsVenous ThromboembolismHematologyMiddle Agedmedicine.diseaseDabigatranPulmonary embolismTreatment OutcomeAnesthesiaOrthopedic surgeryBenzimidazolesFemalebusinessVenous thromboembolismmedicine.drugThrombosis Research
researchProduct

Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal bac…

2013

Background The organic nitrate pentaerithrityl tetranitrate (PETN) has been shown to have ancillary properties that prevent the development of tolerance and endothelial dysfunction. This randomized, double-blind, placebo-controlled, multicentre study (‘CLEOPATRA’ study) was designed to investigate the anti-ischaemic efficacy of PETN 80 mg b.i.d. (morning and mid-day) over placebo in patients with chronic stable angina pectoris. Methods and results A total of 655 patients were evaluated in the intention-to-treat population, randomized to PETN (80 mg b.i.d., n = 328) or placebo ( n = 327) and completed the study. Patients underwent treadmill exercise tests at randomization, after 6 and 12 wee…

Malemedicine.medical_specialtyRandomizationmedicine.drug_classVasodilator AgentsPopulationAdrenergic beta-AntagonistsPlacebo-controlled studyPlaceboAdrenergic beta-AntagonistsMedication AdherenceDouble-Blind MethodmedicineClinical endpointHumansPentaerythritol TetranitrateAngina StableEndothelial dysfunctioneducationBeta blockereducation.field_of_studyExercise Tolerancebusiness.industryMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeAnesthesiaDelayed-Action PreparationsChronic DiseaseExercise TestFemaleCardiology and Cardiovascular MedicinebusinessEuropean heart journal
researchProduct

Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse.

2009

Objective: To assess the effects of an antiseptic, non-alcohol based mouth-rinse containing chlorhexidine and cetylpyridinium chloride, in preventing the oral complications associated to radiation therapy in head-and-neck cancer patients. Study design: This was a parallel, double blind, prospective, randomized clinical trial. Cancer patients were randomly assigned to one of the two treatments (test mouth-rinse or a placebo). Three visits were scheduled (baseline, 14 and 28 days). Different outcome variables were evaluated: mucositis, plaque and gingival indices, stimulated saliva and salivary pH. Results: 70 patients were screened and 36 were included. The presence and the degree of mucosit…

Malemedicine.medical_specialtySalivamedicine.drug_classMouthwashesDentistryCetylpyridiniumPlaceboCetylpyridinium chloridelaw.inventionchemistry.chemical_compoundAntisepticRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineMucositisHumansProspective StudiesRadiation InjuriesGeneral DentistryStomatitisbusiness.industryChlorhexidineChlorhexidineCancerMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOtorhinolaryngologychemistryHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASAnti-Infective Agents LocalSurgeryFemalebusinessmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercho…

2013

Hypercholesterolemic patients (n = 1,547) at high atherosclerotic cardiovascular disease risk with low-density lipoprotein cholesterol (LDL-C) levels ≥100 and ≤160 mg/dl while treated with atorvastatin 10 mg/day entered a multicenter, randomized, double-blind, active-controlled, clinical trial using two 6-week study periods. Period I compared the efficacy/safety of (1) adding ezetimibe 10 mg (ezetimibe) to stable atorvastatin 10 mg, (2) doubling atorvastatin to 20 mg, or (3) switching to rosuvastatin 10 mg. Subjects in the latter 2 groups who persisted with elevated LDL-C levels (≥100 and ≤160 mg/dl) after period I, entered period II; subjects on atorvastatin 20 mg had ezetimibe added to th…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaAtorvastatinHypercholesterolemiaUrologylaw.inventionchemistry.chemical_compoundEzetimibeRandomized controlled trialDouble-Blind Methodlawhealth services administrationInternal medicineprimary hypercholesterolemiaatorvastatin; ezetimibe; rosuvastatin; primary hypercholesterolemiamedicineAtorvastatinHumansRosuvastatinIn patientPyrrolescardiovascular diseasesRosuvastatin CalciumAgedSulfonamidesCholesterolbusiness.industryAnticholesteremic Agentsnutritional and metabolic diseasesCholesterol LDLMiddle AgedEzetimibeClinical trialFluorobenzenesRosuvastatin CalciumLogistic ModelsPyrimidineschemistryHeptanoic AcidsCardiologyAzetidineslipids (amino acids peptides and proteins)Drug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessrosuvastatinmedicine.drugThe American journal of cardiology
researchProduct